Acute Rhinosinusitis
Inflammation of the nasal mucosal and paranasal sinuses lasting up to 4 weeks casued by allergens, environmental irritants, and or infection (virus [majority], bacteria, and fungi).
Acute Bacterial Rhinosinusitis
Secondary bacerial infection of paranasal sinuses
* usually following viral URI
* relatively uncommon Less than 2%
* Majority will resolve without Abx
Most common bacterial causes of ABRS
Diseases cuased by S. pnemoniae
Diseases caused by H. Influenzae
Diseases Casued by M. catarrhalis
Most common fetures of Acute Bacterial Rhiniosinusitis
Treatment of ABRS
Initial ABX regimens for ABRS
ABRS in penicillin allergy
ARBS treatment failure in 3-5 days
Medication Substrate
a medication that is metabolized/biotransformed by the isoenzyme (CYP450 34A) usually found in the liver, inorder for the drug to reach site of action and be eliminated
Ex: sildenafil, atorvostatin, simvastatin, alprazolam
Inhibitor
a drug or substance that blocks the activity of the isoenyme (CYP450 34A), limiting substrate excretion, allowing increase in substrate levels, with possible risk of substrate-induced toxicity
* ex: erythromycin, clarithromycin = CYP450 inhibitor
* concomitant use of one of these abx plus drugs that are CYP450 34A substrates will result in increase in substrate levels by decresing iotransformation and elimination.
* ex: Clrithromycin + simvastatin = statin induced rhabdomyolisis risk
* ex: clarithromycin + alprazolam = increased sedation and fall risk
Inducer
Accelerates the activity of the isoenzyme (CYP450 34A) so that the substrate is pushed out the exit pathway, leading to a reduction in substrate level causing dimished therapudic effect, possible treatment failure
* Ex: St john’s wort + COC = off loading estrogen/progestin= spotting and potential contraceptive failure
Conductive hearing loss
Sensorineural hearing loss
Common cold Vs. Flu/COVID
Allergic rhinitis treatment
inflammatory, IgE-mediated, characterized by nasal congestion, rhinorrhea, sneezing, intraocular and/or nasal itching.
1. Allergen avoidance
2. Controller therapy - prevent symptoms by preventing formation of or inactivating inflammatory mediators
* Intranasal corticosteroids 1st line (fluticasone, triamcinolone) - up to a week for relief
* Intranasal antihistamine - azelastine - rapid symptom relief
3. Reliver therapy - to relieve acute symptoms by blocking histamine
* 2nd gen oral antihistamine - loratadine, certirazine, levocetirazine
* ocular antihistamine
Therapies not reccomended: Leukotrine modifier (montelukast) or systemic corticosteroids
Oral Cancer
Sqamous Cell Carcinoma 95% cases, HPV16 contributing factor
Risks Factors: Longstanding HPV infection, Tabacco use, alcohol misuse
Presentation: painless, ulcerating oral lesion, usually present many months prior to presenting clincally. Adjacent lymphadenopathy = imobile, nontender node usually >1cm
Dx: referral for bx
angle -closure glaucoma
Macular degeneration
open angle glaucoma
Bacterial Vs. Viral Pharyngitis
Bacterial
* significant anterior cervicle lymphadenopathy
* frontal headaches without body aches
* patchy exudates in posterior pharynx - bad breath
* sudden onset
Viral
* Clear nasal drainage
* horseness
* scattered small vessicles on soft palate and tonsils
* generalized body aches
* sore throat preceeded by nasal drainage
Exudative pharygitis treatment